Leukapheresis Market Report 2026

Leukapheresis Market Overview

• Leukapheresis market size has reached to $72.02 billion in 2025 • Expected to grow to $104.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Increasing Prevalence Of Autoimmune Diseases Driving Market Growth Through Targeted Treatment Innovations • Market Trend: Advancing Cell Therapy Through High-Quality, Regulatory-Compliant Starting Materials • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Leukapheresis Market?

Leukapheresis is a medical procedure that involves separating and removing white blood cells (leukocytes) from a person's blood. The remaining components, such as red blood cells and plasma, are then returned to the body. This technique is used to treat conditions involving high white blood cell counts or to collect specific immune cells for research or therapy. The main types of leukapheresis are granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis is a procedure that selectively separates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products include leukapheresis devices, centrifugal devices, membrane separators, and leukapheresis disposables. Applications span across research applications, cancer research, immunology research, therapeutic applications, hematologic disorders, autoimmune diseases, and others, and are used by blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and transfusion centers.

What Is The Leukapheresis Market Growth Forecast?

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $104.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growth in car-t and cell-based therapies, increasing investment in immunology research, rising demand for personalized medicine, expansion of biopharmaceutical manufacturing, technological advancements in apheresis automation. Major trends in the forecast period include rising use of leukapheresis in cell and gene therapies, increasing demand for immune cell collection in oncology, growing adoption of automated apheresis systems, expansion of leukapheresis in clinical research, increasing focus on patient-safe disposable apheresis kits.

Global Leukapheresis Market Segmentation

1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis 2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables 3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications 4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers Subsegments: 1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis 2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis 3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

What Is The Driver Of The Leukapheresis Market?

The rise of autoimmune diseases is expected to propel the growth of the leukapheresis market going forward. Autoimmune diseases refer to conditions where the immune system mistakenly attacks the body’s own healthy tissues. Reduced early-life microbial exposure and modern environmental factors are disrupting immune balance, leading to more autoimmune disorders. Leukapheresis helps treat autoimmune diseases by selectively removing harmful white blood cells that contribute to the immune system attacking the body's own tissues. For instance, inSeptember 2025, according to the GetValue.co, a US-based online digital platform, autoimmune diseases affect an estimated 3–10% of the global population, equating to roughly 600–800 million people worldwide. Therefore, the rise of autoimmune diseases is driving the growth of the leukapheresis industry.

Key Players In The Global Leukapheresis Market

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

Global Leukapheresis Market Trends and Insights

Major companies operating in the leukapheresis market are focusing on advancements such as developing GMP-grade leukopaks to enhance the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high viability and functionality of collected cells for therapeutic applications. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCert offers high-quality starting materials available in fresh whole or half packs, produced according to strict GMP standards, thereby empowering researchers to advance their research and bring new cell therapies to market faster.

What Are Latest Mergers And Acquisitions In The Leukapheresis Market?

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, partnered with Cyto-care.eu GmbH to enhance the cryopreservation process for cell therapy in Europe. Their partnership specifically targets improving the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are critical components in the manufacturing of advanced cell therapy products (ATMPs). Cyto-Care.eu GmbH is an Austria-based company specializing in providing cell products for biomedical research, drug discovery, and cell and gene therapy.

Regional Insights

North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Leukapheresis Market?

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Leukapheresis Market Report 2026?

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.